ALASTIN Skincare has been issued two new patents from the U.S. Patent and Trademark Office, bringing the total number of ALASTIN U.S. patents to six, along with a seventh patent issued in Canada.
U.S. Patent No.11,052,032 covers ALASTIN's platform TriHex Technology and U.S. Patent No. 11,103,455 relates to liposomal compositions, both associated with TransFORM Body Treatment. These new patents are directed to methods for the use of topical compositions of TransFORM Body Treatment with TriHex Technology to improve skin laxity, texture or crepiness, with or without body contouring procedures or for targeting dermal white adipose tissue.
"We are immensely proud of the scientific rigor we have established in validating the TriHex Technology performance in our product formulations, which is confirmed by our numerous patents," said Alan Widgerow, MBBCh (MD); MMed (MHS); FCS; FACS and chief medical officer at ALASTIN. "This is particularly relevant to this TransFORM Body product where disruptive new science has allowed us to make great progress in aiding skin tightening and body contouring."
